Ditchcarbon
  • Contact
  1. Organizations
  2. Valneva
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 7 hours ago

Valneva

Company website

Valneva SE, a prominent biotechnology company headquartered in France, is dedicated to developing and commercialising innovative vaccines for infectious diseases. Founded in 2013, Valneva has rapidly established itself in the global vaccine industry, with significant operations across Europe and North America. The company focuses on creating unique vaccine solutions, including its flagship product, the inactivated vaccine for Lyme disease, which stands out for its advanced technology and efficacy. Valneva's commitment to addressing unmet medical needs has positioned it as a key player in the market, achieving notable milestones such as partnerships with leading pharmaceutical firms and successful clinical trials. With a strong emphasis on research and development, Valneva continues to drive advancements in vaccine technology, contributing to global health initiatives.

DitchCarbon Score

How does Valneva's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

47

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Valneva's score of 47 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Valneva's reported carbon emissions

In 2024, Valneva reported total carbon emissions of approximately 59,000,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 55,534,000 kg CO2e. Scope 1 emissions were approximately 1,277,000 kg CO2e, while Scope 2 emissions totalled about 2,499,000 kg CO2e. In comparison, the previous year, 2023, Valneva's total emissions were about 4,751,000 kg CO2e, with Scope 1 at approximately 1,688,000 kg CO2e, Scope 2 at about 1,477,000 kg CO2e, and Scope 3 at around 1,586,000 kg CO2e. Valneva has made notable strides in reducing its carbon footprint. Since 2019, the company has achieved a 48% reduction in its Scope 1 and 2 emissions, equating to a decrease of approximately 1,630 tonnes CO2e, primarily through a shift to green electricity. Looking ahead, Valneva aims to further reduce its CO2 emissions from laboratories and manufacturing sites by 50% from a 2022 baseline by 2030, encompassing both Scope 1 and 2 emissions. Valneva's commitment to sustainability is evident in its comprehensive approach to emissions management, focusing on both immediate reductions and long-term targets. The company continues to monitor and report its emissions transparently, aligning with industry standards and climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
1,629,000
0,000,000
0,000,000
Scope 2
1,289,000
0,000,000
0,000,000
Scope 3
-
0,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Valneva's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Valneva is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Valneva is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Moderna

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Csl

AU
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Bharat Biotech Ltd.

IN
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy